Our Mission

Strokes and severe traumatic brain injuries are the number one cause of preventable disability.

Our aim is to aid medical personnel and support them in their effort to detect, monitor, and manage brain conditions in real-time.

We strive to improve patient outcomes and increase efficiency of care through our cutting-edge Sense technology.

Our Mission

Strokes and severe traumatic brain injuries are the number one cause of preventable disability.

Our aim is to aid medical personnel and support them in their effort to detect, monitor, and manage brain conditions in real-time.

We strive to improve patient outcomes and increase efficiency of care through our cutting-edge Sense technology.

Our Vision

We’re building a future where Sense technology can complement subjective methods of assessment and monitor physical brain conditions in real-time.

We’re making real-time brain monitoring a reality in the field, as well as in the hospital.

Our Vision

We’re building a future where Sense technology can complement subjective methods of assessment and monitor physical brain conditions in real-time.

We’re making real-time brain monitoring a reality in the field, as well as in the hospital.

Team

Geoff Klass

Geoff Klass

CEO

Respected senior executive in business and community leadership. With over 30 years of building commercial organizations, from startups to global enterprises; Geoff has a deep healthcare and neuro innovation background.

Daniel Kincaid

Daniel Kincaid

COO

Serial entrepreneur, and seed-stage investor with 25 years of experience as a healthcare executive. Dan provides strategic planning, bringing to the table expert mentoring and market validation.

Opeolu Adeoye

Opeolu Adeoye

MD, CMO

Head of the Department of Emergency Medicine at Washington University School of Medicine in St. Louis, where he is the inaugural BJC HealthCare Distinguished Professor of Emergency Medicine.
George Shaw

George Shaw

MD, PhD, CTO

Responsible for the technical and scientific development of Sense device, Dr. Shaw shares a unique vision of improving care for emergency medicine patients. He provides the clinical structure and the highest standards for experiment methodology and data analysis.

Joe Korfhagen

Joe Korfhagen

PhD, Director, R&D

As Director of R&D, Joe focuses on developing the Sense device and enhancing the technology driving the product. Joe’s career goal is to create medical devices that will improve the standard of care for patients suffering from neurological disease.

Matt Flaherty

Matt Flaherty

MD, CCO

Dr. Flaherty practices general neurology with an emphasis on stroke care. He is a prolific author in the area of cerebrovascular disease and was awarded the Michael S. Pessin Stroke Leadership Prize by the American Academy of Neurology in 2009.

Paul Gaitan

Paul Gaitan

CFO

Paul Gaitan is a seasoned CFO with experience most recently with Haag-Streit USA and Workhorse Group. Paul earned his BS degree in business from the University of Southern California and his MBA from Stanford University with a concentration in production control systems.

Board of Directors

Daniel Geeding

Daniel Geeding

Board Chair, Director

Daniel Geeding is a professor emeritus of management and former director of the Center for International Business at Xavier University. Served as dean of Xavier’s Williams College of Business and as director of the college’s Center for Management and Professional Development and the Executive MBA Program.

Jack Kraeutler

Jack Kraeutler

Director

Jack Kraeutler is former CEO of Meridian Bioscience, Inc., whose distinguished career includes more than 45 years of experience in the biomedical industry. He has held numerous board positions, and was also an appointed member of the Ohio Third Frontier Commission and former vice-chair of BIOSTART.

Sally Evans Kay

Sally Evans Kay

Director

Sally Evans Kay is a corporate innovator and mentor whose career includes 36 years with the Dow Chemical Company and GlaxoSmithKline Consumer Healthcare, where she held positions in R&D, finance, sales, marketing and new product development and innovation.

Geoff Klass

Geoff Klass

CEO

Daniel Kincaid

Daniel Kincaid

COO

Opeolu Adeoye

Opeolu Adeoye

MD, CMO

Roger A. Edwards

Roger A. Edwards

CPA

Specialist in business and technology consulting, Roger works closely with regional entrepreneurs, providing both the business and technical guidance needed to assist with developing and commercializing new solutions within a variety of different markets.

Scientific Advisory Board

Lori Shutter

Director of Neurocritical Care & Vice Chair Of Education, Critical Care Medicine

James Grotta, MD

Neurologist, Vascular Neurologist, Director of Stroke Research, Director Mobile Stroke Unit, Memorial Hermann Hospital

John Tew

Professor of Neurosurgery at the University of Cincinnati and UC Health

Harry van Loveren

David W. Cahill Professor and Chair of Neurosurgery at the University of South Florida

David Wright, MD

Professor at Emory University School of Medicine

Investment to Date

Queen City Angels

(Cincinnati)

Accelerant Fund

(Dayton, OH)

Strategic NeuroPhysician Investors

National Science Foundation

Frontier Angels

Anges Quebec

Contact Us

Our team works diligently to make our innovative brain scanner a reality for patients.

We are driven by our mission and are committed to impacting people’s lives and enhancing neurological health globally.

Copyright Sense Neuro 2021 All Rights Reserved. Designed by Node